RESUMO
BACKGROUND: The coronavirus disease 2019 (COVID-19) is a global crisis. The month of Ramadan has coincided with the COVID-19 crisis in 2020. AIM: The aim of this study is to investigate knowledge, attitude, and practices (KAP) toward the preventive measures during Ramadan 2020 and quarantine, among the Egyptian population. METHOD(S): This cross-sectional study is conducted among Egyptians >=15 years of age. A convenience sample of 1150 responders is taken, over the period of the month of Ramadan 2020. An online self-administrated questionnaire is used and shared through social networks. KAP toward preventive measures for COVID-19 during Ramadan are assessed. RESULT(S): Results show that mean scores of KAP are higher among participants >20 years, mean +/- SD (3 +/- 1.1, 5.6 +/- 1.4, and 11.2 +/- 2.6, respectively). A significant difference is found between KAP scores and age with p-values (0.012, 0.002, and 0.000, respectively). Furthermore, there is a significant difference between practices score and gender (p = 0.010). Greater Cairo has the highest KAP mean scores, in comparison with other regions, mean +/- SD (3.3 +/- 1, 5.8 +/- 1.2, and 11.6 +/- 2.5, respectively). A significant difference is recorded between urban and rural areas, regarding KAP with p-value (0.000, 0.050, and 0.000, respectively). CONCLUSION(S): In conclusion, low KAP scores are recorded among participants below the age of 20, and in rural areas and regions outside Greater Cairo. Low practices are associated more with males than females. The present study recommends raising awareness through the use of mass media, and health education programs that are to be directed to male members of the population, people under 20 years old, and to people residing in rural areas and in regions outside Greater Cairo, such as Upper and Lower Egypt, and border regions.Copyright © 2022 Suzan Hagag, Amira B. Kassem, Noha A El-Bassiouny, Sherouk M Okda, Mohammed Mustafa Abdel Razik Mohammed.
RESUMO
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes severe acute respiratory syndrome (SARS). It was discovered in December 2019 in Wuhan, China., which subsequently led to a nationwide outbreak. The World Health Organization included the AstraZeneca and Sinopharm vaccines for the WHO Emergency Use List on February 16 and May 7, 2021, respectively. Egyptians have gotten 2,623,200 doses of AstraZeneca's COVID-19 vaccination plus 500,000 doses of Sinopharm vaccine. The trial would test the vaccinations' short-term side effects on Egyptian people aged 18 and older. Result(s): Most symptoms decreased significantly after the second dose when compared to symptoms seen at the first dose .In addition, both doses reduced symptoms significantly compared to the first dose.Interestingly, the desire to sleep appears to significantly increase the side effects again after both doses when compared to the second dose alone. The majority or nearly all of the participants (96.5%) had no infection after vaccination. Conclusion(s): Mild to moderate side effects are to be expected after the vaccination process because the body's immunomodulatory instructions can lead to negative symptoms. Symptoms include injection site soreness, fever, tiredness, headache, muscle aches, chills, and diarrhoea.. The majority or nearly all of the participants (96.5%) had no infection after vaccination. Training and continuing education are needed to improve universal vaccine acceptance and reduce frequency. Copyright © 2022 Assiut University. All rights reserved.